Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.22.61 (
caspase-8
)
6,833
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Glioblastoma is the most common primary brain tumor in adults and one of its hallmarks is resistance to apoptosis. Acyl-CoA: cholesterol acyltransferase (ACAT) is an intracellular membrane-bound enzyme that uses cholesterol and long chain fatty acyl-CoA as substrates to produce cholesteryl esters. The presence of cholesteryl esters in glioblastoma may be related to vascular and/or cell neoplastic proliferation in the tumor mass, two prerequisites for tumor cell growth. ACAT activity has been detected in glioblastoma cell homogenates. The present study is the first report on the effect of
Avasimibe
, a specific inhibitor of ACAT, on glioma cell lines (U87, A172 and GL261). Our results showed that
Avasimibe
inhibited ACAT-1 expression and cholesterol ester synthesis in glioma cell lines. Moreover,
Avasimibe
inhibited the growth of the cells by inducing cell cycle arrest and induced apoptosis as a result of
caspase-8
and caspase-3 activation. Also, Our findings provide proof of principle that targeting ACAT-1 with the inhibitor
Avasimibe
could be an efficient therapy in the treatment of glioblastoma.
...
PMID:Acyl-coenzyme A: cholesterol acyltransferase inhibitor Avasimibe affect survival and proliferation of glioma tumor cell lines. 2040 12